Free Trial

Insider Selling: Liquidia Technologies, Inc. (NASDAQ:LQDA) Insider Sells 2,576 Shares of Stock

Liquidia Technologies logo with Medical background

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) insider Jason Adair sold 2,576 shares of the firm's stock in a transaction dated Monday, July 14th. The stock was sold at an average price of $14.28, for a total transaction of $36,785.28. Following the transaction, the insider directly owned 193,634 shares in the company, valued at approximately $2,765,093.52. This represents a 1.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Jason Adair also recently made the following trade(s):

  • On Monday, April 28th, Jason Adair sold 455 shares of Liquidia Technologies stock. The shares were sold at an average price of $14.24, for a total value of $6,479.20.

Liquidia Technologies Price Performance

Shares of Liquidia Technologies stock traded down $0.20 during trading on Friday, reaching $14.41. 929,859 shares of the company's stock were exchanged, compared to its average volume of 1,301,913. The company has a debt-to-equity ratio of 2.08, a quick ratio of 2.91 and a current ratio of 2.93. Liquidia Technologies, Inc. has a 1-year low of $8.26 and a 1-year high of $19.41. The company has a market cap of $1.23 billion, a P/E ratio of -9.14 and a beta of -0.01. The firm's 50-day moving average price is $14.88 and its 200 day moving average price is $14.48.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). Liquidia Technologies had a negative return on equity of 177.91% and a negative net margin of 903.80%. The firm had revenue of $3.12 million during the quarter, compared to analyst estimates of $3.23 million. As a group, research analysts anticipate that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current year.

Institutional Investors Weigh In On Liquidia Technologies

A number of institutional investors have recently made changes to their positions in the stock. Bank of New York Mellon Corp boosted its position in shares of Liquidia Technologies by 3.3% during the 4th quarter. Bank of New York Mellon Corp now owns 188,584 shares of the company's stock valued at $2,218,000 after purchasing an additional 6,034 shares in the last quarter. Steward Partners Investment Advisory LLC bought a new stake in shares of Liquidia Technologies during the 4th quarter valued at about $59,000. Charles Schwab Investment Management Inc. boosted its position in shares of Liquidia Technologies by 9.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 428,570 shares of the company's stock valued at $5,040,000 after purchasing an additional 38,313 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of Liquidia Technologies during the 4th quarter valued at about $218,000. Finally, Swiss National Bank boosted its position in shares of Liquidia Technologies by 20.6% during the 4th quarter. Swiss National Bank now owns 107,900 shares of the company's stock valued at $1,269,000 after purchasing an additional 18,400 shares in the last quarter. Institutional investors own 64.54% of the company's stock.

Analyst Upgrades and Downgrades

LQDA has been the subject of a number of recent analyst reports. Raymond James Financial upped their target price on Liquidia Technologies from $27.00 to $29.00 and gave the company a "strong-buy" rating in a research report on Friday, May 9th. HC Wainwright upped their target price on Liquidia Technologies from $29.00 to $35.00 and gave the company a "buy" rating in a research report on Wednesday, May 28th. Scotiabank upped their target price on Liquidia Technologies from $36.00 to $37.00 and gave the company a "sector outperform" rating in a research report on Wednesday, May 28th. Needham & Company LLC reiterated a "buy" rating on shares of Liquidia Technologies in a research report on Monday, June 2nd. Finally, BTIG Research reiterated a "buy" rating on shares of Liquidia Technologies in a research report on Tuesday, May 27th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, six have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $26.89.

Check Out Our Latest Stock Report on LQDA

About Liquidia Technologies

(Get Free Report)

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Read More

Insider Buying and Selling by Quarter for Liquidia Technologies (NASDAQ:LQDA)

Should You Invest $1,000 in Liquidia Technologies Right Now?

Before you consider Liquidia Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Liquidia Technologies wasn't on the list.

While Liquidia Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines